======= TAPBPL =======
== Gene Information ==
* **Official Symbol**: TAPBPL
* **Official Name**: TAP binding protein like
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55080|55080]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BX59|Q9BX59]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TAPBPL&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAPBPL|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607081|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the antigen processing and presentation pathway, which binds to MHC class I coupled with beta2- microglobulin/B2M. Association between TAPBPR and MHC class I occurs in the absence of a functional peptide-loading complex (PLC). Expression seems to slow down and down-regulate MHC class I surface expression. {ECO:0000269|PubMed:23401559}.
|C1-set|
|V-set|
|peptide antigen assembly with MHC class I protein complex|
|MHC class I protein complex assembly|
|negative regulation of antigen processing and presentation of peptide antigen via MHC class I|
|regulation of antigen processing and presentation of peptide antigen via MHC class I|
|negative regulation of antigen processing and presentation of peptide antigen|
|peptide antigen assembly with MHC protein complex|
|MHC class I protein complex binding|
|regulation of antigen processing and presentation of peptide antigen|
|MHC protein complex assembly|
|negative regulation of antigen processing and presentation|
|regulation of antigen processing and presentation|
|antigen processing and presentation of peptide antigen via MHC class I|
|antigen processing and presentation of peptide antigen|
|antigen processing and presentation|
|protein-containing complex binding|
|negative regulation of immune system process|
|Golgi membrane|
|cellular protein-containing complex assembly|
|endoplasmic reticulum membrane|
|protein-containing complex assembly|
|regulation of immune system process|
|protein-containing complex subunit organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-1.7|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.474|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16285
* **Expression level (log2 read counts)**: 4.65
{{:chemogenomics:nalm6 dist.png?nolink |}}